| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Comment on ‘‘patient preferences for CDK4/6 inhibitor treatments in HR + /HER2– early breast cancer: a discrete choice survey study’’
|
Zhang, Wei
|
|
|
211 |
2 |
p. 545-546
|
artikel
|
| 2 |
Development of a prediction model for ctDNA detection (Cir-Predict) in breast cancer
|
Nakauchi, Chiaki
|
|
|
211 |
2 |
p. 331-339
|
artikel
|
| 3 |
Evaluating PREDICT and developing outcome prediction models in early-onset breast cancer using data from Alberta, Canada
|
Basmadjian, Robert B.
|
|
|
211 |
2 |
p. 399-408
|
artikel
|
| 4 |
Examining factors associated with experiencing cardiac arrhythmias in Black and White breast cancer survivors who received anthracyclines or trastuzumab
|
Sutton, Arnethea L.
|
|
|
211 |
2 |
p. 537-544
|
artikel
|
| 5 |
Factors associated with locoregional recurrence after neoadjuvant chemotherapy for breast cancer in a safety-net medical center
|
Brabender, Danielle
|
|
|
211 |
2 |
p. 517-526
|
artikel
|
| 6 |
FGFR4 in endocrine resistance: overexpression and estrogen regulation without direct causative role
|
Ding, Kai
|
|
|
211 |
2 |
p. 501-515
|
artikel
|
| 7 |
Genetic counseling referral rates and genetic testing outcomes in women with young breast cancer: a 20-year Canadian review
|
Randall Armel, Susan
|
|
|
211 |
2 |
p. 321-330
|
artikel
|
| 8 |
Goserelin 3-month depot shows non-inferiority to the monthly formulation in U.S. patients with premenopausal breast cancer: a real-world evidence study
|
McCann, Kelly E.
|
|
|
211 |
2 |
p. 409-419
|
artikel
|
| 9 |
High risk surveillance MRI may not be necessary in BRCA1/2 mutation carriers over 70 years old
|
Botty van den Bruele, Astrid
|
|
|
211 |
2 |
p. 421-429
|
artikel
|
| 10 |
IGF1R activates FOXP3-β-catenin signaling to promote breast cancer development
|
Li, Lu
|
|
|
211 |
2 |
p. 467-478
|
artikel
|
| 11 |
IHC4 and COMBINE scores for enhanced prognostic stratification in HR+/HER2− breast cancer patients after neoadjuvant chemotherapy
|
Huang, Zhenhua
|
|
|
211 |
2 |
p. 307-319
|
artikel
|
| 12 |
Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer
|
Shinn, Eileen
|
|
|
211 |
2 |
p. 385-397
|
artikel
|
| 13 |
Is the risk of local recurrence higher for microinvasive breast cancer vs. early stage invasive breast cancer?
|
Hardy Abeloos, Camille
|
|
|
211 |
2 |
p. 479-487
|
artikel
|
| 14 |
Long-term outcomes of volume de-escalation for breast nodal irradiation
|
Colciago, Riccardo Ray
|
|
|
211 |
2 |
p. 375-384
|
artikel
|
| 15 |
Mammographic density as a predictor of invasive breast cancer and ductal carcinoma in situ in over six million South Korean women
|
Kim, Sung Hun
|
|
|
211 |
2 |
p. 341-350
|
artikel
|
| 16 |
National trends and survival outcomes associated with non-guideline-concordant treatment of inflammatory breast cancer
|
Kronen, Elsa A.
|
|
|
211 |
2 |
p. 527-535
|
artikel
|
| 17 |
Oncotype DX recurrence score in node-positive patients in the post-RxPONDER era: a single-institution experience
|
Han, Rachel
|
|
|
211 |
2 |
p. 449-454
|
artikel
|
| 18 |
Perceptions of breast cancer risk after breast density notification in a population-based screening program
|
‘t Hart, Dorinda
|
|
|
211 |
2 |
p. 455-465
|
artikel
|
| 19 |
Postoperative radiotherapy improves long-term survival in HER2-positive metastatic breast cancer: real-world evidence from the latest SEER database
|
Xie, Ling-Xiao
|
|
|
211 |
2 |
p. 489-500
|
artikel
|
| 20 |
PTEN inactivating mutations are associated with hormone receptor loss during breast cancer recurrence
|
Zhan, Haiying
|
|
|
211 |
2 |
p. 441-447
|
artikel
|
| 21 |
Risk-guided cardioprotection with carvedilol in patients with breast cancer (CCT guide): a phase 1 randomized clinical trial
|
Jung, Wonyoung
|
|
|
211 |
2 |
p. 293-305
|
artikel
|
| 22 |
Somatostatin receptor-targeted theranostics in patients with estrogen receptor-positive metastatic breast cancer—a prospective exploratory study
|
Chandekar, Kunal Ramesh
|
|
|
211 |
2 |
p. 363-373
|
artikel
|
| 23 |
Targeting “don’t eat me” signal: breast cancer immunotherapy
|
Gao, Yue
|
|
|
211 |
2 |
p. 277-292
|
artikel
|
| 24 |
The impact of loco-regional treatment on ipsilateral breast cancer recurrence and outcomes in carriers of BRCA1/2 pathogenic variants
|
Bernstein-Molho, Rinat
|
|
|
211 |
2 |
p. 431-439
|
artikel
|
| 25 |
Treatment patterns and outcomes in HER2-low metastatic breast cancer patients previously treated with chemotherapy: a US real-world cohort study
|
Modi, Shanu
|
|
|
211 |
2 |
p. 351-362
|
artikel
|
Tijdschrift beschrijving